Common Contracts
1 similar Variation Agreement contracts
CONTRACT VARIATION AGREEMENT No.2Variation Agreement • January 27th, 2022
Contract/Variation Reference: NHS England, Biogen, Spinal Muscular Atrophy UK, TreatSMA, Muscular Dystrophy UK, SMA REACH UK and NICE entered into a managed access agreement dated 3 July 2019, and varied on 18 May 2021, relating to the agreed terms and conditions according to which patients will be entitled to access the drug called nusinersen (Spinraza®) for treatment for 5q Spinal Muscular Atrophy (SMA) NICE TA588 (the “MAA”).
